Low concentrations of actinomycin D potentially cause therapeutic differentiation in human rhabdomyosarcoma cell line RD.

[1]  J. Prados,et al.  Differentiation of a human rhabdomyosarcoma cell line after antineoplastic drug treatment , 1995, The Journal of pathology.

[2]  J. Prados,et al.  Actinomycin D causes multidrug resistance and differentiation in a human rhabdomyosarcoma cell line. , 1994, Cellular and molecular biology.

[3]  V. Ninfo,et al.  Therapy associated differentiation in rhabdomyosarcomas. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[4]  J. Coindre,et al.  Expression of MDR1/P glycoprotein in human sarcomas. , 1993, British Journal of Cancer.

[5]  K. Kiura,et al.  MDR1 gene expression and treatment outcome in small cell lung cancer: MDR1 gene expression as an independent prognostic factor. , 1993, Acta medica Okayama.

[6]  J. Prados,et al.  Actin, tropomyosin and alpha-actinin as markers of differentiation in human rhabdomyosarcoma cell lines induced with dimethyl sulfoxide. , 1993, Cellular and molecular biology.

[7]  I. Roninson,et al.  MDR-1 expression in metastatic malignant melanoma. , 1993, The Journal of surgical research.

[8]  S. Kaye.  P glycoprotein (P-gp) and drug resistance--time for reappraisal? , 1993, British Journal of Cancer.

[9]  H. Akan,et al.  P-Glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine a containing protocols , 1992, Medical oncology and tumor pharmacotherapy.

[10]  L. Truong,et al.  Comparative immunohistochemical staining for desmin and muscle-specific actin. A study of 576 cases. , 1991, American journal of clinical pathology.

[11]  M. Bouché,et al.  12-O-tetradecanoylphorbol-13-acetate-induced differentiation of a human rhabdomyosarcoma cell line. , 1990, Cancer research.

[12]  C. Gerharz,et al.  Heterogeneous response to differentiation induction in different clonal subpopulations of a rat rhabdomyosarcoma cell line (BA-HAN-1). , 1989, Cancer research.

[13]  R. Kodet,et al.  Rhabdomyosarcoma in childhood. An immunohistological analysis with myoglobin, desmin and vimentin. , 1989, Pathology, research and practice.

[14]  P. Lollini,et al.  Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs. , 1989, Cancer research.

[15]  H. Hassan,et al.  Low concentrations of cytosine arabinoside, 6-thioguanine, actinomycin-d and aclacinomycin a stimulates the differentiation of normal human marrow myeloid progenitor cells , 1989, Medical oncology and tumor pharmacotherapy.

[16]  G. Butler-Browne,et al.  [Rhabdomyosarcomas discovered in newborn infants. Study of markers of muscle differentiation]. , 1989, Annales de pathologie.

[17]  L. Sachs.  Cell differentiation and bypassing of genetic defects in the suppression of malignancy. , 1987, Cancer research.

[18]  A. Bloch,et al.  Mechanism of interaction between antineoplastic agents and natural differentiation factors in the induction of human leukemic cell maturation. , 1986, Cancer research.

[19]  D. Sens,et al.  The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line. , 1986, The American journal of pathology.

[20]  M. Reiss,et al.  Induction of tumor cell differentiation as a therapeutic approach: preclinical models for hematopoietic and solid neoplasms. , 1986, Cancer treatment reports.

[21]  A. Sartorelli.  The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach. , 1985, British Journal of Cancer.

[22]  R. Freshney.  Induction of differentiation in neoplastic cells. , 1985, Anticancer research.

[23]  A. Sartorelli,et al.  Characterization of the metabolic forms of 6‐thioguanine responsible for cytotoxicity and induction of differentiation of HL‐60 acute promyelocytic leukemia cells , 1984, Journal of cellular physiology.

[24]  J. Oosterhuis,et al.  Cytologic "differentiation" in childhood rhabdomyosarcomas following polychemotherapy. , 1984, Human pathology.

[25]  A. Jongsma,et al.  Isolation and characterization of subclones of L1210 murine leukemia with different sensitivities to various cytotoxic agents. , 1983, Cancer research.

[26]  H. H. Lloyd,et al.  Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells. , 1978, Seminars in hematology.

[27]  G. Clements.  Selection of biochemically variant, in some cases mutant, mammalian cells in culture. , 1975, Advances in cancer research.